Afternoon Symposia

Learn about clinical breakthroughs and advances in patient care during the educational symposia at the Society of Critical Care Medicine's (SCCM) 46th Critical Care Congress. Each stimulating session is presented by leading experts in critical care and offers a thorough analysis of the developments and issues affecting most intensive care unit (ICU) environments.

These symposia will be held Sunday, January 22, 2017, at the Hilton Hawaiian Village. Seating is on a first-come, first-served basis. These sessions are complimentary for all Congress registrants, and no additional registration is needed to attend. Light refreshments and beverages will be available before each symposium, beginning at 3:00 p.m. The sessions will start promptly at 3:30 p.m.

Please note: Transportation between the Hawaii Convention Center and the Hilton Hawaiian Village ends at 2:30 p.m. 


 Anticoagulant Therapy


Anticoagulant Therapy: Where We Are and Where We Are Heading
Supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and CSL Behring L.L.C.
Room: Tapa Ballroom 3, Tapa Tower, Hilton Hawaiian Village


  • Non-Vitamin K Antagonist Oral Anticoagulants
    William E. Dager, PharmD, BCPS, MCCM
  • New Antiplatelet Agents: Thienopyridines
    Philip S. Barie, MD, MBA, MCCM, FCCM 
  • Emergent Management of Bleeding and Reversal of Anticoagulant and Antiplatelet Agents
    Michael B. Yaffe, MD, PhD

Learning Objectives

  • Identify existing and new anticoagulants
  • Discuss the different mechanisms of actions and label indications as well as short- and long-term untoward effects
  • Discuss reversal and counteracting agents in cases of urgent and emergent medical indications

 Hepatorenal Syndrome


Evidence-Based Management of Hepatorenal Syndrome Type 1 in Critical Care: Preserving Renal Function in Patients with Portal Hypertension
Supported by an educational grant from Mallinckrodt Pharmaceuticals
Room: Tapa Ballroom 1, Tapa Tower, Hilton Hawaiian Village

Moderator: Azra Bihorac, MD, MS, FCCM


  • Hepatorenal Syndrome: Current Knowledge on Pathology and Definitions
    Azra Bihorac, MD, MS, FCCM
  • Assessment and Differential Diagnosis of Hepatorenal Syndrome in Cirrhotic Patients
    Ram M. Subramanian, MD
  • Critical Care Team Decision-Making: Plasma Revolumization and Timing of Pharmacologic Options
    William J. Peppard, PharmD, BCPS

Learning Objectives

  • Describe the etiology of portal hypertension and other pathologies leading to vasoconstriction of the renal bed and development of hepatorenal syndrome (HRS)
  • Discuss International Club of Ascites (ICA) criteria for diagnosis of type 1 and 2 HRS with other guidelines available for staging of acute kidney injury
  • Apply proactive management, including evidence-based pharmacotherapy, to patients showing rapid SCr elevation, and meet other criteria for HRS based on the ICA guidelines



The Modern Approach to the Diagnosis and Treatment of Shock
Supported by an educational grant from La Jolla Pharmaceutical Company
Room: Tapa Ballroom 2, Tapa Tower, Hilton Hawaiian Village

Moderator: Raghavan Murugan, MD, MS, FRCP


  • Emerging Therapeutic Strategies
    Ashish K. Khanna, MD, FCCP
  • Preserving End-Organ Perfusion
    Laurence W. Busse, MD
  • Volumetric Assessment in Shock
    Raghavan Murugan, MD, MS, FRCP

Learning Objectives

  • Identify the various subtypes of shock
  • Recognize the manifestations of and differentiate the various shock syndromes
  • Assess the current clinical tools, guidelines and clinical evidence supporting the use of vasopressors in treating shock
  • Discuss emerging treatment options for treating shock